Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS☆
暂无分享,去创建一个
W. Markesbery | R. Havlik | D. Davis | D. Foley | L. Launer | L. White | G. Ross | H. Petrovitch | W. Markesbery | J. Hardman | G. Izmirilian | J. Nelson | Ross Gw
[1] C. DeCarli,et al. Predictors of brain morphology for the men of the NHLBI twin study. , 1999, Stroke.
[2] Y. Yamamoto,et al. Relationship between brain atrophy estimated by a longitudinal computed tomography study and blood pressure control in patients with essential hypertension. , 1999, Japanese circulation journal.
[3] L. Allegri,et al. Hypertension as an Etiopathological Factor in the Development of Cerebral Atrophy in Hemodialyzed Patients , 1999, Nephron.
[4] C. DeCarli,et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology , 1998, Neurology.
[5] K. Davis,et al. The relationship between apolipoprotein E, dementia, and vascular illness. , 1998, Atherosclerosis.
[6] M. Mullan,et al. Characteristics of thein VitroVasoactivity of β-Amyloid Peptides , 1998, Experimental Neurology.
[7] C. Kessler,et al. Apolipoprotein E4 Promotes Incipient Alzheimer Pathology in the Elderly , 1998, Alzheimer disease and associated disorders.
[8] W. Markesbery,et al. N‐terminal Heterogeneity of Parenchymal and Cerebrovascular Aβ Deposits , 1998, Journal of neuropathology and experimental neurology.
[9] Yasuo Terayama,et al. Normal human aging: factors contributing to cerebral atrophy , 1997, Journal of the Neurological Sciences.
[10] D. Davis,et al. Microscope field size and the neuropathologic criteria for Alzheimer's disease , 1997, Neurology.
[11] D. Sparks. Coronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease? , 1997, Annals of the New York Academy of Sciences.
[12] J. Bogousslavsky,et al. Presymptomatic hypertension is a major feature in the diagnosis of progressive supranuclear palsy. , 1997, Archives of neurology.
[13] G. Alexander,et al. Interactive effects of age and hypertension on volumes of brain structures. , 1997, Stroke.
[14] S. M. Sumi,et al. Clinical-neuropathologic findings in multi-infarct dementia , 1997, Neurology.
[15] J. Lindsay,et al. The Canadian Study of Health and Aging: risk factors for vascular dementia. , 1997, Stroke.
[16] D J Foley,et al. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. , 1996, JAMA.
[17] D. Sparks,et al. Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients , 1996, Journal of the Neurological Sciences.
[18] B. Lernfelt,et al. 15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.
[19] R. Havlik,et al. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. , 1995, JAMA.
[20] C. Morris,et al. Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians , 1995, Neuroscience Letters.
[21] D. Sparks,et al. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension , 1995, Journal of the Neurological Sciences.
[22] T. Hashimoto,et al. [A longitudinal study of brain atrophy and its relation with background factors and common carotid hemodynamics]. , 1994, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.
[23] 英忠 佐々木,et al. アルツハイマー型老年痴呆 (SDAT) と「ビンスワンガー型白質病変」 , 1994 .
[24] E P Steinberg,et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. , 1994, Stroke.
[25] O. Faergeman,et al. Genotyping compared with protein phenotyping of the common apolipoprotein E polymorphism. , 1994, Clinica chimica acta; international journal of clinical chemistry.
[26] G. Baumbach. Changes in the Cerebral Circulation in Chronic Hypertension , 1994 .
[27] The Human Brain Circulation , 1994, Vascular Biomedicine.
[28] R. D'Agostino,et al. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. , 1993, American journal of epidemiology.
[29] V. Hachinski,et al. Rethinking Vascular Dementia (Part 1 of 2) , 1993 .
[30] Y. Stern,et al. Confusion and memory loss from capsular genu infarction , 1992, Neurology.
[31] J. Haxby,et al. Brain atrophy in hypertension. A volumetric magnetic resonance imaging study. , 1992, Hypertension.
[32] W. Jagust,et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.
[33] A. Burns. Clinical diagnosis of Alzheimer's disease , 1991 .
[34] Norman E. Breslow,et al. Tests of Hypotheses in Overdispersed Poisson Regression and other Quasi-Likelihood Models , 1990 .
[35] K. Arima,et al. Severe cerebral atrophy in progressive supranuclear palsy: a case report. , 1989, Clinical neuropathology.
[36] A. Paetau,et al. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[37] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.